z-logo
open-access-imgOpen Access
Efficacy of a multigenic protein vaccine containing multimeric HIV gp160 against heterologous SHIV clade C challenges
Author(s) -
Robert A. Rasmussen,
Helena Ong,
Ruijiang Song,
AgnèsLaurence Chenine,
Mila AyashRashkovsky,
Shiu-Lok Hu,
Patricia Polacino,
James G. Else,
Francis J. Novembre,
Ruth M. Ruprecht
Publication year - 2007
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32828684ea
Subject(s) - immunogen , heterologous , virology , biology , vaccination , aids vaccines , hiv vaccine , antibody , neutralizing antibody , immune system , immunogenicity , virus , lentivirus , viral load , gene , immunology , vaccine trial , viral disease , genetics , monoclonal antibody
To determine whether multigenic protein immunogens including native, trimeric HIV clade C (HIV-C) gp160 could cross-protect macaques against mucosal challenge with clade C (SHIV-C) mismatched for env.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom